According to the results of the first nine months of 2012 total sales of the top five best selling prescription medications amounted to RUR 872.0 million, which corresponds to 30.9% of sales in the prescription medications segment and 21.0%[1] of the Company's total sales.
According to the results of the first nine months of 2012 the top five best selling prescription medications are:
- Geptor (Ademetionine; ATC[2] «Digestive tract and metabolism»); sales in the prescription medications segment made 10.2%;
- Vero-epoetin (Epoetin beta, ATC «Antineoplastic and immunomodulating agents»); sales in the segment made 6.5%;
- Irunine (Itraconazole; ATC «Antimicrobials for systematic use»); sales in the segment made 4.9%;
- Doxorubicin (Doxorubicin, ATC «Antineoplastic and immunomodulating agents»); sales in the segment made 4.7%;
- Carboplatin-LANS (Carboplatin; ATC «Antineoplastic and immunomodulating agents»); sales in the segment made 4.6%
The OTC drugs segment is characterized by the high degree of consolidation. It means that the top five best selling medicines make 98.6% of sales.
- Xilen (Xylometazoline; ATC «Medications for the treatment of respiratory system»); sales increased by 23.8% as compared to the same period of previous year; sales in the OTC drugs segment made 63.5%;
- Slabilen (Sodium picosulfate; ATC «Alimentary tract and metabolism»); 19.2% of sales in the OTC drugs segment;
- Motilak (Domperidone; ATC «Alimentary tract and metabolism»); sales in the OTC drugs segment made 11.1%;
- Vitasharm and Vitatress (ATC «Vitamins»); sales in the OTC drugs segment made 3.6%;
- Ginecotex (Benzalknium chloride; ATC «Medications for the treatment of urogenital organs»); sales increased by 13.4% as compared to the same period of previous year; sales in the OTC drugs segment made 1.2%.
According to the results of the first nine months of 2012 the top five best selling traditional drugs are:
- Vero-Dexamethasone (Dexamethasone; ATC «Hormonal drugs for systematic use»); 42.7% of sales in the traditional drugs segment;
- Fluconazole (Fluconazole; ATC «Antimicrobials for systematic use»); 14.3% of sales in the traditional drugs segment;
- Vero-Loperamide (Loperamide; ATC «Alimentary tract and metabolism»); 7.9% of sales in the traditional drugs segment;
- Pyridoxine (Pyridoxine; ATC «Alimentary tract and metabolism»); 16.6% of sales in the traditional drugs segment;
- Vero-ciprofloxacin (Ciprofloxacin, «Antimicrobials for systematic use»); 11.6% of sales in the traditional drugs segment.
According to the results of the first nine months of 2012 the top five best selling non-pharamaceutical products are:
- Conventional antimicrobial adhesive bandages; 48.7% of sales in the segment;
- Conventional reel adhesive bandages; 22.4% of sales in the segment;
- Therapeutic plasters - pepper plasters; 11.3% of sales in the segment;
- Therapeutic plasters - corn plasters; 15.8% of sales in the segment;
- Cosmetic products (Veromistin Silver, Daily, Flores); 0.9% of sales in the segment.
During the first nine months of 2012 Veropharm started production and sales of the new forms and dosages of the drugs:
- Poludan (Polyadenilic acid + Polyuridilic acid; ATC «Medications for the sense organs treatment»); new dosage - nasal drops 50 IU[3]/ml 5 ml ¹1;
- Aprotex (Aprotinin, ATC «Medications affecting hematogenesis and blood»); new dosages - 10000 KIU[4]]/ml 10 ml ¹1, 10000 KIU/ml 50 ml ¹ 1 and 10000 KIU/ml 10 ml ¹ 25;
- Bergolak (Cabergoline; ATC «Medications for the urinogenital organs treatment»); new dosage - tabl. 0.5 mg ¹2;
- Mielastra (Filgrastim; ATC «Antineoplastic and immunomodulating agents»); new dosages - 30 mln IU/ml 1.6 ml ¹1 and 30 mln IU/ml 1 ml ¹5;
- Vero-Netilmicin (Netilmicin; ATC «Antimicrobials for systematic use»); new dosage - solution for injection 25mg/ml 2 ml ¹1;
- Tautax (Docetaxel; ATC «Antineoplastic and immunomodulating agents»); new dosage - 20 mg/ml 2 ml ¹1;
- Cerepro (Choline alfoscerate; ATC «Medications for the treatment of central nervous system deseases»); new dosage - 250 mg/ml 4 ml ¹5;
- Rubida (Idarubicin, «Antineoplastic and immunomodulating agents»); new dosage - 1 mg/ml 10 ml ¹1;
- Torin (Sertraline; ATC «Medications for the treatment of central nervous system deseases»); new dosage - tabl. 0.05g ¹28.
During the first nine months of 2012 Veropharm received registration for the following drugs:
- Topotecan (Topotecan, ATC «Antineoplastic and immunomodulating agents»); new dosage - liophilizate for infusion solution 1 mg;
- Veromistin Silver (Benzyldimethyl-myristoikamino-propylammonium monohydrate, ATC "Medications for dermatopathy treatment"); new form - napkins for intimate hygiene;
- Veromistin Daily (Benzyldimethyl-myristoikamino-propylammonium monohydrate, ATC "Medications for dermatopathy treatment"); new form - cleaning wet towels.
Additionally, 14 more drugs are currently at different stages of the registration process.
[1] % - percent of finished goods sales
[2] ATC - anatomico-therapeutico-chemical group
[3] IU - international units
[4] KIU - kallikrein-inactivated unit
Press-release
distributed by |